Viewing Study NCT00003666


Ignite Creation Date: 2025-12-24 @ 4:13 PM
Ignite Modification Date: 2026-01-04 @ 7:03 AM
Study NCT ID: NCT00003666
Status: COMPLETED
Last Update Posted: 2016-07-20
First Post: 1999-11-01
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Irofulven in Treating Patients With Relapsed or Refractory Non-small Cell Lung Cancer
Sponsor: Alliance for Clinical Trials in Oncology
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: CALGB-39805
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NIH View